Related Experiment Video
Updated: Feb 16, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Fluorination Enhances Serum Stability of Bioreducible Poly(amido amine) Polyplexes and Enables Efficient Intravenous
Gang Chen1, Kaikai Wang1, Yixin Wang1
1State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, 210009, China.
Abstract:
The use of small interfering RNA (siRNA) in cancer treatment has been limited by the lack of effective systemic delivery methods. Although synthetic polycations have been widely explored in siRNA delivery, polycation/siRNA polyplexes often suffer from insufficient stability in vivo. Here, rationally designed siRNA delivery systems that meet the requirements for systemic siRNA delivery to distant tumors are reported. The hypothesis that modular design of delivery systems based on poly(amido amine)s that combine fluorination for systemic stability with bioreducibility for easy intracellular siRNA release, and PEGylation for improved safety and colloidal stability will overcome problems with contradicting siRNA delivery demands is tested. PEGylated, fluorinated, and bioreducible copolymers (PEG-PCD-F) with different degree of fluorination are thus synthesized. The fluorinated copolymers readily formed polyplexes with siRNA and achieved greatly improved gene silencing efficacy in multiple cell lines in vitro when compared with nonfluorinated controls. The results show fluorination-induced enhancement of stability, cellular uptake, and endosomal escape of the polyplexes, while exhibiting efficient siRNA release in reducing intracellular environment. PEG-PCD-F polyplexes with siRNA against Bcl2 inhibit breast tumor growth following systemic intravenous administration. The results provide strong evidence of successful combination of bioreducibility with fluorination and PEGylation to achieve systemic siRNA polyplex delivery.
Insights
New siRNA delivery systems enhance cancer treatment by combining fluorination, bioreducibility, and PEGylation for improved stability and targeted tumor delivery, overcoming previous limitations in systemic administration.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Therapeutics
Background:
- Systemic delivery of small interfering RNA (siRNA) for cancer treatment is hindered by poor stability and inefficient delivery of polycation/siRNA polyplexes.
- Existing delivery methods often face challenges in balancing stability, cellular uptake, and intracellular release of siRNA.
Purpose of the Study:
- To develop and test a novel modular siRNA delivery system (PEG-PCD-F) combining fluorination, bioreducibility, and PEGylation.
- To overcome the limitations of current siRNA delivery systems for effective systemic delivery to distant tumors.
Main Methods:
- Synthesis of PEGylated, fluorinated, and bioreducible copolymers (PEG-PCD-F) with varying degrees of fluorination.
- Formation of polyplexes with siRNA and evaluation of their stability, cellular uptake, and gene silencing efficacy in vitro.
- Assessment of in vivo tumor growth inhibition following systemic administration of PEG-PCD-F/siRNA polyplexes in a breast cancer model.
Main Results:
- Fluorinated copolymers formed stable polyplexes with siRNA, demonstrating enhanced gene silencing in vitro compared to non-fluorinated controls.
- Fluorination improved polyplex stability, cellular uptake, and endosomal escape, while maintaining efficient siRNA release in the intracellular environment.
- Systemic intravenous administration of PEG-PCD-F/siRNA targeting Bcl2 significantly inhibited breast tumor growth in vivo.
Conclusions:
- The combination of bioreducibility, fluorination, and PEGylation in a modular design offers a promising strategy for effective systemic siRNA delivery.
- The developed PEG-PCD-F system successfully addresses the conflicting demands of siRNA delivery for enhanced cancer therapy.
- This approach provides strong evidence for overcoming previous barriers in achieving stable and efficient systemic siRNA delivery to tumors.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
RNA Stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Amines to Amides: Acylation of Amines
Next, the second equivalent of amine serves as a Brønsted base and deprotonates the quaternary...
Nuclear Stability
To hold positively charged protons together...

